We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.49B
Cap. Flow %
-16.94%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126
Avg Time Held Equity + Options
3.2 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.7 quarters
Avg Time Held Equity only
3.2 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.7 quarters

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.77%
3 Healthcare 15.9%
4 Miscellaneous 8.89%
5 Real Estate 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
PSPC
576
DELISTED
Post Holdings Partnering Corporation
PSPC
$2.27M 0.03%
233,953
-23,421
-9% -$228K
2022 Q1
2 quarters
PICC
577
DELISTED
Pivotal Investment Corporation III
PICC
$2.26M 0.03%
229,322
-23,466
-9% -$231K
2021 Q2
5 quarters
SHEL icon
578
Shell
SHEL
$294B
$2.25M 0.03%
45,303
-3,012
-6% -$155K
2022 Q1
2 quarters
MTAL icon
579
DELISTED
Metals Acquisition
MTAL
$2.25M 0.03%
229,785
-23,003
-9% -$225K
2021 Q3
4 quarters
DYN icon
580
Dyne Therapeutics
DYN
$2.86B
$2.24M 0.03%
176,490
-50,868
-22% -$583K
2022 Q1
2 quarters
XLF icon
581
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.4B
$2.21M 0.03%
+1,200,000
New +$39.7M
2022 Q3
0 quarters
FNVT icon
582
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.17M 0.02%
214,762
-21,499
-9% -$216K
2021 Q4
3 quarters
DNAD
583
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.15M 0.02%
218,128
-21,836
-9% -$213K
2021 Q2
5 quarters
TXNM icon
584
TXNM Energy Inc
TXNM
$6.45B
$2.14M 0.02%
+46,872
New +$2.23M
2022 Q3
0 quarters
DY icon
585
Dycom Industries
DY
$8.07B
$2.14M 0.02%
22,377
+3,422
+18% +$358K
2022 Q2
1 quarter
CITE icon
586
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.13M 0.02%
210,558
-21,079
-9% -$212K
2022 Q2
1 quarter
DOC icon
587
Healthpeak Properties
DOC
$13B
$2.09M 0.02%
91,011
-139,174
-60% -$3.68M
2022 Q1
2 quarters
ANAB icon
588
AnaptysBio
ANAB
$1.4B
$2.08M 0.02%
81,668
+702
+0.9% +$16.5K
2022 Q1
2 quarters
RIG icon
589
PUT
Transocean
RIG
$6.39B
$2.07M 0.02%
1,967,700
– –
2018 Q2
17 quarters
ON icon
590
ON Semiconductor
ON
$28.8B
$2.04M 0.02%
+32,770
New +$2.11M
2022 Q3
0 quarters
VLO icon
591
Valero Energy
VLO
$131B
$2.04M 0.02%
19,053
-1,253
-6% -$138K
2022 Q2
1 quarter
MTRY
592
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
$2.03M 0.02%
190,898
-19,111
-9% -$192K
2021 Q4
3 quarters
O icon
593
Realty Income
O
$51.7B
$2.02M 0.02%
34,718
+10,597
+44% +$731K
2021 Q4
3 quarters
GMFI icon
594
DELISTED
Aetherium Acquisition Corp
GMFI
$2.02M 0.02%
203,024
-157,300
-44% -$1.56M
2022 Q1
2 quarters
SDGR icon
595
Schrodinger
SDGR
$1.92B
$1.99M 0.02%
79,547
+5,000
+7% +$147K
2022 Q1
2 quarters
MRK icon
596
Merck
MRK
$358B
$1.96M 0.02%
+22,800
New +$2.04M
2022 Q3
0 quarters
PTGX icon
597
Protagonist Therapeutics
PTGX
$9.06B
$1.96M 0.02%
232,820
+13,000
+6% +$123K
2022 Q1
2 quarters
XENE icon
598
Xenon Pharmaceuticals
XENE
$3.35B
$1.96M 0.02%
54,208
-42,000
-44% -$1.51M
2022 Q1
2 quarters
GFX
599
DELISTED
Golden Falcon Acquisition Corp.
GFX
$1.95M 0.02%
195,521
-19,656
-9% -$195K
2021 Q1
6 quarters
IOVA icon
600
Iovance Biotherapeutics
IOVA
$6.58B
$1.94M 0.02%
202,872
-54,000
-21% -$623K
2022 Q1
2 quarters

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.49B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.